Abnormal multiple marker screens are associated with adverse perinatal outcomes in cases of intrauterine growth restriction

This publication has 16 references indexed in Scilit:

• Unexplained elevated maternal serum α-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes
  American Journal of Obstetrics and Gynecology, 2003
• Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome
  Obstetrics & Gynecology, 1998
• Elevated second trimester human chorionic gonadotropin level associated withadverse pregnancy outcome
  International Journal of Gynecology & Obstetrics, 1997
• Undetectable maternal serum unconjugated estriol levels in the second trimester: Risk of perinatal complications associated with placental sulfatase deficiency
  American Journal of Obstetrics and Gynecology, 1997
• Do growth-retarded premature infants have different rates of perinatal morbidity and mortality than appropriately grown premature infants?
  Obstetrics & Gynecology, 1996
• Elevated second-trimester maternal serum hcg alone or in combination with elevated alpha-fetoprotein
  Obstetrics & Gynecology, 1996
• Maternal Serum Triple Analyte Screening and Adverse Pregnancy Outcome
  Fetal Diagnosis and Therapy, 1996
• Pregnancy outcome for women with very low levels of maternal serum unconjugated estriol on second-trimester screening
  American Journal of Obstetrics and Gynecology, 1995
• Second-Trimester Maternal Serum Alpha-Fetoprotein Levels and the Risk of Subsequent Fetal Death
  New England Journal of Medicine, 1991
• Elevated maternal serum α-fetoprotein levels associated with breakdown in fetal-maternal-placental barrier
  American Journal of Obstetrics and Gynecology, 1983